Am I the Same Patient I Was Before Getting Pregnant? Drug Selection, Pharmacokinetics, and Pharmacodynamics in Pregnancy

Bonus CE Session

CE: 1.0

Bonus CE Session Moderator(s)

Richard Pino, MD, PhD, FCCM

Professor and Head Dept of Anesthesiology
LSU Health Sciences Center
New Orleans, Louisiana

No relevant financial relationship(s) to disclose

This session will cover the implications of pharmacokinetic and pharmacodynamic changes that occur with pregnancy, properties of medications that allow them to cross the placenta, medications that should not be administered to the mother based on risk to the fetus, and venous thromboembolism treatment and prophylaxis of the pregnant patient that account for alterations to the volume of distribution.

Learning Objectives:

Discuss the implications of pharmacokinetic and pharmacodynamic changes that occur with pregnancy and the properties of medications that allow them to cross the placenta
Identify medications that should not be administered to the mother based on risk to the fetus
Explore venous thromboembolism treatment and prophylaxis for the pregnant patient based on alterations to the volume of distribution
Describe common symptoms in pregnancy such as leg swelling, palpitations, blood pressure changes, and shortness of breath and discuss the differential diagnosis
Discuss the latest updates on how COVID-19 affects pregnant patients, as well as different treatments, extracorporeal membrane oxygenation, and fetal outcomes

Presentations:

Will My Body Ever Be the Same?
Bonus CE Session Faculty: Elizabeth A. Farrington, BCNSP, BCPS, PharmD – New Hanover Regional Medical Center
Medication Choices: Does Pregnancy Make a Difference?
Bonus CE Session Faculty: Erin Wieruszewski, BCCCP, PharmD – Mayo Clinic
VTE Prophylaxis and VTE/PE Treatment in the Pregnant Patient
Bonus CE Session Faculty: Brenda M. Engler, ACNP, BS, CCRN, MSN – Geisinger Medical Center Danville